	Cytiva announced on June 24, 2020 that it has completed a renovation of its Fast Trak cGMP contract biomanufacturing and process development site in Marlborough, MA.

	The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000, according to a company press release. The site offers technical support and single-use biomanufacturing expertise to biotechnology companies looking for assistance in bringing therapeutics to market.

	“Biotechnology companies are increasingly outsourcing their manufacturing, whether to access expertise, capacity, or both,” said Olivier Loeillot, senior vice-president, BioProcess at Cytiva, in the press release. “Our upgraded Fast Trak cGMP facility will provide our customers, particularly the small to mid-size companies, with the services and expertise needed to help expedite their processes and get to market faster.”

Facility Design and Engineering

PharmTech News

Supplier News

The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000L. 